BioEnergy International, a privately-held developer of biofuels and renewable biochemicals based in Quincy, MA, said it has acquired certain assets from Cambridge, MA-based OmniGene Bioproducts. The acquisition gives BioEnergy skilled employees in molecular biology, cell biology and fermentation technology, the company said. Financial terms of the agreement weren’t disclosed.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
